Discovery Boulevard
Open menu

About Discovery Boulevard

Discovery Boulevard is a bioinformatics company that develops computational drug discovery software, delivers research services and consultancy, and trains researchers through hands-on workshops. We bridge the gap between complex biological data and actionable insights for scientists and research organizations worldwide.

Founded
2024
Headquarters
Imphal, Manipur, India
Registered MSME
UDYAM-MN-05-0023854

What we do

Software

We build and operate our own computational drug discovery pipeline, from protein target to analysed simulation data, and develop new methods where existing options fall short.

Explore the platform

Research services

CADD consultancy and project work for academic and industry groups: target assessment, ligand design, virtual screening, QSAR, molecular dynamics and custom pipeline deployment.

See our services

Training

Live hands-on workshops that teach researchers the same validated workflows we use in our own projects.

Browse training

Our story

Discovery Boulevard was established by a team of passionate bioinformatics researchers who saw that advanced bioinformatics tools and resources needed to be far more accessible. What began as small workshops has grown into large-scale consultancy projects and an in-house drug discovery pipeline that we develop and operate ourselves.

Our vision

To empower researchers worldwide by providing access to cutting-edge bioinformatics tools, training and consultancy, bridging scientific research with practical innovation.

Our mission

  1. 01Develop computational drug discovery software and methods where existing options fall short.
  2. 02Deliver high-quality bioinformatics services and consultancy that accelerate research.
  3. 03Provide hands-on training and workshops for researchers working with biological data.
  4. 04Build a supportive global community that connects scientific potential with real-world outcomes.

Training and capacity building

Discovery Boulevard is equally invested in building scientific capacity through a variety of training programs and workshops. These initiatives cover topics such as molecular docking, virtual screening, and bioinformatics workflows, helping researchers upskill and stay at the forefront of scientific discovery.

  • Free workshops
  • Week-long training
  • Month-long projects

Core competencies

  • Structure-Based Drug Design (SBDD)
  • Ligand-Based Drug Design (LBDD)
  • Molecular Docking and Virtual Screening
  • Pharmacophore Modeling and Screening
  • Molecular Dynamics Simulations
  • Lead Optimization & Hit Identification
  • ADMET & Toxicity Prediction
  • QSAR Model Development
  • Multi-Ligand Docking Automation
  • AI-Powered Target Discovery

Leadership

Founder and partner

Dr. Angamba Meetei Potshangbam

Dr. Angamba Meetei Potshangbam

Co-founder

Discovery Boulevard · Co-founder, Algobiome LLP

Dr. Angamba Meetei Potshangbam is the co-founder of Discovery Boulevard, where he leads the development of computational drug discovery software, automated pipelines and new methods. He holds a Ph.D. and works at the intersection of structural biology, simulation and artificial intelligence.

His work focuses on building end-to-end in silico workflows that connect molecular docking, molecular dynamics simulation, MixMD cosolvent mapping, virtual screening, QSAR and AI-driven molecular design into reproducible, scalable pipelines. He develops desktop applications and automation tools for docking, MD, binding-pocket prediction and 3D-QSAR, and works on new approaches for allosteric site discovery and structure-based ligand design.

Under his leadership, Discovery Boulevard partners with academic and industry groups on research and consulting projects, delivering computational solutions from target analysis to lead prioritization. He also shares this expertise through hands-on training, having worked with approximately 5,000 researchers and students.

He is also the co-founder of Algobiome LLP, which focuses on scientific software and AI-driven methods.

Google Scholar

Dr. Ruchi Jakhmola Mani

Dr. Ruchi Jakhmola Mani

Partner

Discovery Boulevard · Director, Algobiome LLP

Dr. Ruchi Jakhmola Mani is a Partner at Discovery Boulevard and Director at Algobiome LLP, where she helps lead the development of AI-driven methods and computational solutions for biomedical research. She is a neuroscientist with over 14 years of research experience, including her academic work at the Proteomics and Translational Research Laboratory, Amity University Noida.

Her expertise lies in disease modeling across neurology, oncology and diabetes, combining preclinical research with in silico and AI-based approaches. Her contributions include work on artificial intelligence in neuroscience, computational evaluation of natural compounds in Alzheimer's disease, and new assessment methods for zebrafish models. At Discovery Boulevard and Algobiome, she brings this biological depth to the design of computational pipelines, ensuring that new tools and methods address real research questions.

She holds several granted and published patents and copyrights, and has published with Nature, Elsevier, Springer, Taylor and Francis, Bentham Science and IntechOpen, among others.

Google Scholar

Guidance

Advisory board

Prof. Rathore

Prof. Rathore

Advisor

Head, Department of Bioinformatics, Central University of South Bihar, Gaya

Prof. Rathore currently serves as the Head of the Department of Bioinformatics at the Central University of South Bihar, Gaya, India. He earned his Ph.D. in Biophysics and Crystallography from the Indian Institute of Science, Bangalore, in 1999, and pursued postdoctoral research in Structural Biology at the University of Texas Medical Branch (UTMB), Galveston, USA.

With over 27 years of experience in teaching and research, he has held positions at leading institutions and organizations including Schrödinger Inc. (USA), the University of Hyderabad and the Tata Institute of Fundamental Research (TIFR). He also served as Dean of the School of Earth, Biological and Environmental Sciences at the Central University of South Bihar from 2016 to 2019.

Prof. Rathore has authored more than 150 research publications and patents, along with online web servers and tools including the widely used Ramplot server. His expertise spans computational molecular drug design, peptide-based biologics, molecular modeling, fMRI-derived connectomics and AI algorithm development for predictive modeling.

Google Scholar

Dr. Ankush Sharma

Dr. Ankush Sharma

Advisor

University of Oslo and Oslo University Hospital

Dr. Ankush Sharma is a computational biologist and bioinformatics leader with over 15 years of experience bridging academia and industry. He currently serves as a researcher at the University of Oslo and Oslo University Hospital, with a career that includes senior industry roles such as Senior Scientist at AstraZeneca (Acerta Pharma).

Dr. Sharma specializes in leveraging high-resolution spatial transcriptomics (Visium HD), single-cell multi-omics and machine learning to map tumor microenvironments and immune escape mechanisms. A prominent figure in the global scientific community, he holds a PhD in Computational Biology and an MBA in Leadership Management, and moderates a LinkedIn network of over 150,000 bioinformatics professionals. He brings strategic technical direction to our board across spatial data architecture, cross-modality validation and AI-driven clinical translation.

Google Scholar

Dr. Pankaj Singh Dholaniya

Dr. Pankaj Singh Dholaniya

Consultant

Assistant Professor, Department of Biotechnology and Bioinformatics, University of Hyderabad

Dr. Pankaj Singh Dholaniya is an interdisciplinary researcher working at the intersection of computational biology, biological data science and AI for healthcare discovery. He is an Assistant Professor in the Department of Biotechnology and Bioinformatics at the University of Hyderabad, India, where he leads The Data Biology Group (PankazLab). He previously served as a Postdoctoral Researcher at The Ohio State University Wexner Medical Center, USA.

His research applies machine learning, multi-omics data integration and regulatory network modeling to neurodegenerative and cardiovascular diseases. By combining computational and experimental approaches, his group identifies biomarkers, uncovers disease-associated molecular mechanisms and models therapeutic strategies. As a consultant, he brings this translational, cross-border research perspective to Discovery Boulevard.

Google Scholar

Contact

Connect with us

Questions about a project, our software, a collaboration or an upcoming workshop? Send us a message and we will get back to you.

Opens your email app with the message ready to send.